Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States.
Li, Ang; Carlson, Josh J; Kuderer, Nicole M; Schaefer, Jordan K; Li, Shan; Garcia, David A; Khorana, Alok A; Carrier, Marc; Lyman, Gary H.
Afiliação
  • Li A; Division of Hematology, University of Washington School of Medicine, Seattle, Washington.
  • Carlson JJ; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington School of Pharmacy, Seattle, Washington.
  • Kuderer NM; Advanced Cancer Research Group and Department of Medicine, University of Washington, Seattle, Washington.
  • Schaefer JK; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Li S; Pharmacy Services, University of Washington Medical Center, Seattle, Washington.
  • Garcia DA; Division of Hematology, University of Washington School of Medicine, Seattle, Washington.
  • Khorana AA; Department of Hematology and Medical Oncology, Taussig Cancer Institute and Case Comprehensive Cancer Center, Cleveland Clinic, Cleveland, Ohio.
  • Carrier M; Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Lyman GH; Division of Medical Oncology, University of Washington School of Medicine, Seattle, Washington.
Cancer ; 126(8): 1736-1748, 2020 04 15.
Article em En | MEDLINE | ID: mdl-31999844

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Análise Custo-Benefício / Anticoagulantes Tipo de estudo: Clinical_trials / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Limite: Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Análise Custo-Benefício / Anticoagulantes Tipo de estudo: Clinical_trials / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Limite: Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos